Adaptive Biotechnologies’ initial public offering was worth $2.1 billion to investors, according to a calculation from venture capital database PitchBook.
Adaptive Biotechnologies’ initial public offering was worth $2.1 billion to investors, according to a calculation from venture capital database PitchBook.
About Our Site:
The primary purpose of the site is to provide Real Estate & Mortgage information as it relates to today’s business environment. It can also be used to answer related question you might have about buying, selling, or financing real estate.